Graves'disease is one of the most common autoimmune diseases affecting humans, mainly women. In this disease, autoantib'odies generated by the immune system mimic the action of the pituitary hormone thyrotropin (TSH) thereby activating the TSH receptor on the thyroid gland and causing thyroid gland overactivity. Excess, unregulated thyroid hormone secretion leads to thyrotoxicosis with symptoms and signs affecting all organs in the body. Untreated, the disease can be fatal. Present therapy can treat but not cure Graves'disease. Moreover, there has been no significant advance in treatment in over 50 years. Recent evidence suggests that the molecular structure of the TSH receptor contributes to this autoimmune response. The goal of the present grant proposal is to enhance understanding of TSH receptor structure, particularly the extracellular region with which thyroid stimulating autoantibodies interact. The TSH receptor ectodomain comprises three components:- (i) an N-terminal domain (NTD) containing a cysteine cluster;(ii) a leucine-rich domain (LRD) comprising 9 leucine-rich repeats forming a slightly curved tubular structure. Each repeat has a beta-strand on its concave surface that forms part of the TSH binding region;(iii) a Hinge region bridging the LRD with the transmembrane region of the TSHR. The hinge is the least understood of these three TSHR ectodomain regions because of poor homology with other proteins of known structure. The TSHR hinge region is also unique among the glycoprotein hormone receptors in containing a -50 amino acid segment that is deleted during intramolecular cleavage into disulfide-linked A- and B-subunits. In contrast to the hinge region, the TSH receptor NTD and LRD structures are quite well understood because of the recent determination of the crystal structure of these FSH receptor components (lacking the hinge). However, the spatial inter-relationship between these three TSH receptor ectodomain components is unknown. The methodological approach to be used to investigate the TSH receptor will involve systematic mutagenesis of key amino acid residues chosen on the basis of present structural knowledge. The consequences of these mutations will be assessed structurally (using a large repertoire of monoclonal antibodies) and functionally (intracellular cAMP responses). The data obtained will provide insight into the pathophysiology of Graves'disease that will, hopefully, lead to improved forms of therapy in the future.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK019289-35
Application #
7857947
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Spain, Lisa M
Project Start
1976-05-01
Project End
2011-05-31
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
35
Fiscal Year
2010
Total Cost
$379,274
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
McLachlan, Sandra M; Lesage, Sylvie; Collin, Roxanne et al. (2017) Genes Outside the Major Histocompatibility Complex Locus Are Linked to the Development of Thyroid Autoantibodies and Thyroiditis in NOD.H2h4 Mice. Endocrinology 158:702-713
Ludwig, Ralf J; Vanhoorelbeke, Karen; Leypoldt, Frank et al. (2017) Mechanisms of Autoantibody-Induced Pathology. Front Immunol 8:603
Rapoport, Basil; Banuelos, Bianca; Aliesky, Holly A et al. (2016) Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans. J Immunol 197:4560-4568
Rapoport, Basil; McLachlan, Sandra M (2016) TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective. Endocr Rev 37:114-34
Rapoport, Basil; Aliesky, Holly A; Chen, Chun-Rong et al. (2015) Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease. J Clin Endocrinol Metab 100:E871-5
Rapoport, Basil; Aliesky, Holly A; Banuelos, Bianca et al. (2015) A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor. J Immunol 194:4154-61
Chen, Chun-Rong; Salazar, Larry M; McLachlan, Sandra M et al. (2015) Deleting the Redundant TSH Receptor C-Peptide Region Permits Generation of the Conformationally Intact Extracellular Domain by Insect Cells. Endocrinology 156:2732-8
Chen, Chun-Rong; Hubbard, Paul A; Salazar, Larry M et al. (2015) Crystal structure of a TSH receptor monoclonal antibody: insight into Graves' disease pathogenesis. Mol Endocrinol 29:99-107
McLachlan, Sandra M; Rapoport, Basil (2014) Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev 35:59-105
Rapoport, Basil; McLachlan, Sandra M (2014) Graves' hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J Clin Endocrinol Metab 99:4060-1

Showing the most recent 10 out of 138 publications